APA

Hogeboom van Buggenum I. M., Polak B. C. P., Reichert-Thoen J. W. M., de Vries-Knoppert W. A. E. J., van Hinsbergh V. W. M. & Tangelder G. J. (20020731). Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. : Diabetologia.

Chicago

Hogeboom van Buggenum I M, Polak B C P, Reichert-Thoen J W M, de Vries-Knoppert W A E J, van Hinsbergh V W M and Tangelder G J. 20020731. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. : Diabetologia.

Harvard

Hogeboom van Buggenum I. M., Polak B. C. P., Reichert-Thoen J. W. M., de Vries-Knoppert W. A. E. J., van Hinsbergh V. W. M. and Tangelder G. J. (20020731). Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. : Diabetologia.

MLA

Hogeboom van Buggenum I M, Polak B C P, Reichert-Thoen J W M, de Vries-Knoppert W A E J, van Hinsbergh V W M and Tangelder G J. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. : Diabetologia. 20020731.